| Pongamia pinnata: An Untapped Resource for the Biofuels Industry of the Future PT Scott, L Pregelj, N Chen, JS Hadler, MA Djordjevic, PM Gresshoff Bioenergy Research 1, 2-11, 2008 | 357 | 2008 |
| Deconstructing and reconstructing the capability hierarchy D Hine, R Parker, L Pregelj, ML Verreynne Industrial and Corporate Change 23 (5), 1299-1325, 2014 | 102 | 2014 |
| Precision medicines have faster approvals based on fewer and smaller trials than other medicines L Pregelj, TJ Hwang, DC Hine, EB Siegel, RT Barnard, JJ Darrow, ... Health Affairs 37 (5), 724-731, 2018 | 37 | 2018 |
| Transcription profiling of the isoflavone phenylpropanoid pathway in soybean in response to Bradyrhizobium japonicum inoculation L Pregelj, JR McLanders, PM Gresshoff, PM Schenk Functional Plant Biology 38 (1), 13-24, 2010 | 17 | 2010 |
| Changes in clinical trial length L Pregelj, ML Verreynne, D Hine Nature Reviews. Drug Discovery 14 (5), 307, 2015 | 15 | 2015 |
| Working hard or hardly working? Regulatory bottlenecks in developing a COVID-19 vaccine L Pregelj, DC Hine, MG Oyola-Lozada, TP Munro Trends in Biotechnology 38 (9), 943-947, 2020 | 14 | 2020 |
| Assessing the impact of US Food and Drug Administration breakthrough therapy designation timing on trial characteristics and development speed L Pregelj, DC Hine, AS Kesselheim, JJ Darrow Clinical Pharmacology & Therapeutics 110 (4), 1018-1024, 2021 | 13 | 2021 |
| Adaptive regulation for digital health: enhancing Australia’s regulation system A Stephens, L Pregelj, D Hine, A Smith MTPConnect, 2021 | 4 | 2021 |
| Commercializing university research to mitigate simultaneous change stimuli: An exemplar case from the Australian higher education sector D Hine, L Pregelj, M McManus World Scientific Reference on Innovation: Volume 1: University Technology …, 2018 | 4 | 2018 |
| Capability development along the capability lifecycle: Evidence from the pharmaceutical industry L Pregelj | 4 | 2013 |
| Functional genomics of the regulation of nodule number in legumes PM Gresshoff, G Gualtieri, T Laniya, A Indrasumunar, A Miyahara, ... Biological nitrogen fixation, sustainable agriculture and the environment …, 2005 | 4 | 2005 |
| Delivering impactful solutions for the bioeconomy B Hankamer, L Pregelj, S O’Kane, K Hussey, D Hine Trends in Plant Science, 2023 | 3 | 2023 |
| Restoring Australia’s long-term innovation requires investment in basic research RS Harrison, RT Barnard, L Pregelj Microbiology Australia 44 (1), 57-61, 2023 | 2 | 2023 |
| Speeding up drug development: Productivity and innovation speed in the biosciences L Pregelj, ML Verreynne, D Hine The Australian Graduate School of Entrepreneurship, Swinburne University of …, 2010 | 2 | 2010 |
| Small Pharmaceutical Firms Building Capabilities to Compete Along the Global Research and Development Pipeline L Pregelj, ML Verreynne, D Hine International Entrepreneurship in the Life Sciences, 2011 | 1 | 2011 |
| Anticipatory regulation for pandemic responses: are we there yet? MG Oyola-Lozada, L Pregelj, A Jenkins, E Siegel, T Munro, D Hine Trends in Biotechnology, 2024 | | 2024 |
| Are manufacturing patents to blame for biosimilar market launch delays? R Williamson, T Munro, D Ascher, A Robertson, L Pregelj Value in Health 27 (3), 287-293, 2024 | | 2024 |
| Progress of precision medicines onto the Australian market L Pregelj, D Hine, K Hussey Australasian Biotechnology 28 (3), 38-40, 2018 | | 2018 |
| Trading-Off Innovation Speed for Knowledge During Drug Development L Pregelj, DC Hine, M Becerra, ML Verreynne Academy of Management Proceedings 2018 (1), 15704, 2018 | | 2018 |
| Submission: Commonwealth Department of Health, re Consultation on the Draft Implementation Plan-National Health Genomics Policy Framework M Mangelsdorf, A Crowden, J Lamont, D Hine, D Morrison, K Hussey, ... The University of Queensland, 2018 | | 2018 |
Damian HineUniversity of Queensland在 uq.edu.au 的电子邮件经过验证
